Polymorphic structures of 3-phenyl-1H-1,3-benzodiazol-2(3H)-one

被引:0
作者
Hong, Dabeen
Lee, Kyounghoon [1 ]
机构
[1] Gyeongsang Natl Univ, Dept Chem Educ, Jinju Si 52828, Gyeongsangnam D, South Korea
基金
新加坡国家研究基金会;
关键词
crystal structure; benzimidazolone; hydrogen bond; POTENT; ANALOGS; SERIES; BENZIMIDAZOLONES; VISUALIZATION; INHIBITORS; DISCOVERY; RECEPTOR; DESIGN;
D O I
10.1107/S2056989023003961
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The polymorphic structures (I and II) of 3-phenyl-1H-1,3-benzodiazol-2(3H)-one, C13H10N2O, acquired from pentane diffusion into the solution in THF, are reported. The structures show negligible differences in bond distances and angles, but the C-N-C-C torsion angles between the backbone and the phenyl substituent, 123.02 (15)degrees for I and 137.18 (11)degrees for II, are different. Compound I features a stronger C=O center dot center dot center dot H-N hydrogen bond than that in II, while the structure of II exhibits a stronger pi-pi interaction than in I, as confirmed by the shorter intercentroid distance [3.3257 (8) angstrom in II in comparison to 3.6862 (7) angstrom in I]. Overall, the supramolecular interactions of I and II are distinct, presumably originating from the variation in the dihedral angle.
引用
收藏
页码:534 / +
页数:11
相关论文
共 40 条
[1]   1-(4-Methylbenzy1)-1H-benzimidazol-2(3H)-one [J].
Belaziz, Dounia ;
Rodi, Youssef Kandri ;
Chandi, Fouad Ouazzani ;
Essassi, El Mokhtar ;
Saadi, Mohamed ;
El Ammari, Lahcen .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 :O122-+
[2]   1-Dodecyl-1H-benzo[d]imidazol-2(3H)-one [J].
Belaziz, Dounia ;
Rodi, Youssef Kandri ;
Chahdi, Fouad Ouazzani ;
Essassi, El Mokhtar ;
Saadi, Mohamed ;
El Ammari, Lahcen .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 :O3069-+
[3]   1-Octyl-1H-benzimidazol-2(3H)-one [J].
Belaziz, Dounia ;
Rodi, Youssef Kandri ;
Essassi, El Mokhtar ;
El Ammari, Lahcen .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 :O1276-+
[4]   Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders [J].
Bellenie, Benjamin R. ;
Cheung, Kwai-Ming J. ;
Varela, Ana ;
Pierrat, Olivier A. ;
Collie, Gavin W. ;
Box, Gary M. ;
Bright, Michael D. ;
Gowan, Sharon ;
Hayes, Angela ;
Rodrigues, Matthew J. ;
Shetty, Kartika N. ;
Carter, Michael ;
Davis, Owen A. ;
Henley, Alan T. ;
Innocenti, Paolo ;
Johnson, Louise D. ;
Liu, Manjuan ;
de Klerk, Selby ;
Le Bihan, Yann-Vai ;
Lloyd, Matthew G. ;
McAndrew, P. Craig ;
Shehu, Erald ;
Talbot, Rachel ;
Woodward, Hannah L. ;
Burke, Rosemary ;
Kirkin, Vladimir ;
van Montfort, Rob L. M. ;
Raynaud, Florence, I ;
Rossanese, Olivia W. ;
Hoelder, Swen .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (08) :4047-4068
[5]   PATTERNS IN HYDROGEN BONDING - FUNCTIONALITY AND GRAPH SET ANALYSIS IN CRYSTALS [J].
BERNSTEIN, J ;
DAVIS, RE ;
SHIMONI, L ;
CHANG, NL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1995, 34 (15) :1555-1573
[6]   Potassium Hydroxide/Dimethyl Sulfoxide Promoted Intramolecular Cyclization for the Synthesis of Benzimidazol-2-ones [J].
Beyer, Astrid ;
Reucher, Christine M. M. ;
Bolm, Carsten .
ORGANIC LETTERS, 2011, 13 (11) :2876-2879
[7]   Access to CyclicN-Trifluoromethyl Ureas through PhotocatalyticActivation of Carbamoyl Azides [J].
Bouayad-Gervais, Samir ;
Nielsen, Christian D-T ;
Turksoy, Abdurrahman ;
Sperger, Theresa ;
Deckers, Kristina ;
Schoenebeck, Franziska .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (13) :6100-6106
[8]  
Bruker, 2012, APEX2 SAINT SADABS
[9]   OLEX2: a complete structure solution, refinement and analysis program [J].
Dolomanov, Oleg V. ;
Bourhis, Luc J. ;
Gildea, Richard J. ;
Howard, Judith A. K. ;
Puschmann, Horst .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2009, 42 :339-341
[10]   Benzimidazolone p38 inhibitors [J].
Dombroski, MA ;
Letavic, MA ;
McClure, KF ;
Barberia, JT ;
Carty, TJ ;
Cortina, SR ;
Csiki, C ;
Dipesa, AJ ;
Elliott, NC ;
Gabel, CA ;
Jordan, CK ;
Labasi, JM ;
Martin, WH ;
Peese, KM ;
Stock, IA ;
Svensson, L ;
Sweeney, FJ ;
Yu, CH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) :919-923